Abstract
Idiopathic ventricular fibrillation is a relatively rare cause of lethal arrhythmia, which has gained increased recognition during the last decade. Several therapeutic approaches have been adopted worldwide. The present review discusses these various approaches. Implantation of an automatic defibrillator is the most commonly recommended mode of therapy for patients with idiopathic ventricular fibrillation. Our own results, however, suggest that antiarrhythmic treatment with Class IA agents using an electrophysiologic‐guided approach is possible and may provide a safe and low‐cost alternative to implantable defibrillators in selected cases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
